Advertisement
Screener

MeiraGTx Holdings plc (MGTX) ROE

MeiraGTx Holdings plc (MGTX) ROE

  • 2026-06-30: ROE 36.60%.
  • 2026-03-31: ROE 207.35%.
  • 2025-12-31: ROE 1971.36%.
  • 2025-09-30: ROE 415.93%.

Complete source-backed roe history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3036.60%
2026-03-31207.35%
2025-12-311971.36%
2025-09-30415.93%
2025-06-30-5321.11%
2025-03-31-505.54%
2024-12-31-217.89%
2024-09-30-92.10%
2024-06-30-116.37%
2024-03-31-60.87%
2023-12-31-60.81%
2023-09-30-143.17%
2023-06-30-100.82%
2023-03-31-142.91%
2022-12-31-110.09%
2022-09-30-91.48%
2022-06-30-71.05%
2022-03-31-53.93%
2021-12-31-42.91%
2021-09-30-42.65%
2021-06-30-29.46%
2021-03-31-29.86%
2020-12-31-24.31%
2020-09-30-29.60%
2020-06-30-33.02%
2020-03-31-28.36%
2019-12-31-28.69%
2019-09-30-36.08%
2019-06-30-58.11%
2019-03-31-58.47%
2018-12-31-102.23%
2018-09-30-73.09%
2018-06-30-58.48%
2018-03-3166.69%

Annual ROE

DateROE
2025-12-311971.36%
2024-12-31-217.89%
2023-12-31-60.81%
2022-12-31-110.09%
2021-12-31-42.91%
2020-12-31-24.31%
2019-12-31-28.69%
2018-12-31-102.23%
2017-12-3165.54%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10